These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11212987)

  • 61. Complete clinical responses to neoadjuvant chemotherapy for uterine serous carcinoma.
    Price FV; Amin RM; Sumkin J
    Gynecol Oncol; 1999 Apr; 73(1):140-4. PubMed ID: 10094895
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Resistance to multiple agent chemotherapy including cisplatin after chronic low-dose oral etoposide administration in gestational choriocarcinoma.
    Okamoto T; Goto S
    Gynecol Obstet Invest; 2001; 52(2):139-41. PubMed ID: 11586044
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions.
    Elias AD; Ayash LJ; Wheeler C; Schwartz G; Tepler I; McCauley M; Mazanet R; Schnipper L; Frei E; Antman KH
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):83-5. PubMed ID: 7992072
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Uterine myxoid leiomyosarcoma and CYVADIC-etoposide therapy.
    Fukunishi H; Yukimura N; Takeuchi S; Kitazawa S
    Int J Gynaecol Obstet; 1994 Sep; 46(3):321-4. PubMed ID: 7806003
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Malignant rhabdoid tumor of the liver presented with initial tumor rupture.
    Kachanov D; Teleshova M; Kim E; Dobrenkov K; Moiseenko R; Usychkina A; Filin A; Semenkov A; Mitrofanova A; Konovalov D; Shamanskaya T; Novichkova G; Varfolomeeva S
    Cancer Genet; 2014 Sep; 207(9):412-4. PubMed ID: 24894493
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Double-cycle, high-dose ifosfamide, carboplatin, and etoposide followed by peripheral blood stem-cell transplantation for small cell lung cancer.
    Iwasaki Y; Nagata K; Nakanishi M; Natuhara A; Kubota Y; Ueda M; Arimoto T; Hara H
    Chest; 2005 Oct; 128(4):2268-73. PubMed ID: 16236883
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study.
    Sanson M; Ameri A; Monjour A; Sahmoud T; Ronchin P; Poisson M; Delattre JY
    Eur J Cancer; 1996 Dec; 32A(13):2229-35. PubMed ID: 9038603
    [TBL] [Abstract][Full Text] [Related]  

  • 68. High-dose tamoxifen modulates drug resistance to doxorubicin, dacarbazine and ifosfamide in metastatic uterine leiomyosarcoma.
    Yeh KH; Lu YS; Hsiao CH; Cheng AL
    Anticancer Res; 2003; 23(6D):5133-7. PubMed ID: 14986591
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
    Beyer J; Rick O; Weinknecht S; Kingreen D; Lenz K; Siegert W
    Bone Marrow Transplant; 1997 Nov; 20(10):813-9. PubMed ID: 9404920
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High-dose chemotherapy for salvage treatment of germ cell tumors: Charité, Virchow Klinikum, Berlin.
    Siegert W; Rick O; Beyer J
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S7-9. PubMed ID: 9916622
    [No Abstract]   [Full Text] [Related]  

  • 71. Congenital disseminated malignant rhabdoid tumor of the soft tissue.
    Yurdakul Z; Berrak SG; Bilgen H; Altuncu E; Akman I; Canpolat C; Demiryont M; Ozek E
    Pediatr Blood Cancer; 2007 Sep; 49(3):364-5. PubMed ID: 16862535
    [No Abstract]   [Full Text] [Related]  

  • 72. Modified Ifosphamide/CarboPlatin/Etoposide.
    Snee MP
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):165; author reply 165. PubMed ID: 12801057
    [No Abstract]   [Full Text] [Related]  

  • 73. [Ifosfamide combination chemotherapy for advanced gynecologic malignancies].
    Li X; Liu L; Wu L
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):330-2. PubMed ID: 11778564
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rhabdoid tumor of the kidney presenting with hemiplegia: report of a case.
    Alavi S; Rashidi A; Khatami AR; Arzanian MT
    Pediatr Hematol Oncol; 2007 Mar; 24(2):123-8. PubMed ID: 17454778
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumors.
    Marina NM; Rodman JH; Murry DJ; Shema SJ; Bowman LC; Jones DP; Furman W; Meyer WH; Pratt CB
    J Natl Cancer Inst; 1994 Apr; 86(7):544-8. PubMed ID: 8133538
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.
    Kondagunta GV; Bacik J; Sheinfeld J; Bajorin D; Bains M; Reich L; Deluca J; Budnick A; Ishill N; Mazumdar M; Bosl GJ; Motzer RJ
    J Clin Oncol; 2007 Jan; 25(1):85-90. PubMed ID: 17194908
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Wertheim's hysterectomy after neoadjuvant carboplatin-based chemotherapy in patients with cervical cancer stage IIB and IIIB.
    Meden H; Fattahi-Meibodi A; Osmers R; Krauss T; Kuhn W
    Anticancer Res; 1998; 18(6B):4575-9. PubMed ID: 9891521
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients.
    Motzer RJ; Mazumdar M; Sheinfeld J; Bajorin DF; Macapinlac HA; Bains M; Reich L; Flombaum C; Mariani T; Tong WP; Bosl GJ
    J Clin Oncol; 2000 Mar; 18(6):1173-80. PubMed ID: 10715285
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ifosfamide, carboplatin and etoposide in recurrent malignant glioma.
    Schäfer N; Tichy J; Thanendrarajan S; Kim Y; Stuplich M; Mack F; Rieger J; Simon M; Scheffler B; Boström J; Steinbach JP; Herrlinger U; Glas M
    Oncology; 2011; 80(5-6):330-2. PubMed ID: 21791942
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed müllerian tumors of the uterus.
    Wong L; See HT; Khoo-Tan HS; Low JS; Ng WT; Low JJ
    Int J Gynecol Cancer; 2006; 16(3):1364-9. PubMed ID: 16803531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.